Yelena Janjigian and Norah Lewin Join NBC's Saturday TODAY to Discuss Cycle for Survival's 20th Anniversary
Global Partners Unite to Fund High-Risk, High-Reward Cancer Science - Cancer Grand Challenges
The One Vaccine That Could Save a Generation of Indian Women
SURE-02 Trial: Neoadjuvant Sacituzumab Govitecan + Pembrolizumab in Muscle-Invasive Bladder Cancer
$1M AI Accelerator Grant for Ovarian Cancer Research - Ovarian Cancer Research Alliance
CART19-BE-02 trial: From Bench to Bedside and Beyond - Resonance
Prof. Gevorg Tamamyan Joins the London Global Cancer Week Steering Group
Marty Makary: Approved a MM Drug Just 55 Days After the Application Was Filed
Identify low-risk febrile neutropenia patients using the MASCC (Multinational Association for Supportive Care in Cancer) risk index.
Check if YES (0 points), leave unchecked if NO (+5 points)
Check if YES (0 points), leave unchecked if NO (+4 points)
Check if YES (0 points), leave unchecked if NO (+3 points)
Check if YES (+3 points), leave unchecked if NO (0 points)
Check if YES (+2 points), leave unchecked if NO (0 points)
MASCC Risk Index Scoring:
Risk Classification:
